Ara
Toplam kayıt 6, listelenen: 1-6
Where do these guests come from? A diagnostic approach for metastatic lymph nodes
(Aves, 2018)
Objective: In cases presenting with lymphadenopathies (LAP) without a primary focus detected by simple radiological methods, the primary tumor can be diagnosed by a histopathological evaluation of the metastatic lymph ...
Adropin as a potential marker of enzyme-positive acute coronary syndrome
(Clinics Cardive Publ Pty Ltd, 2017)
Aim: Enzyme-positive acute coronary syndrome (EPACS) can cause injury to or death of the heart muscle owing to prolonged ischaemia. Recent research has indicated that in addition to liver and brain cells, cardiomyocytes ...
Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?
(Wolters Kluwer Medknow Publications, 2020)
Background: Endometrioid-type endometrial carcinoma is the most common malignancy of the female genital tract in developed countries. The prognosis greatly depends on the grade and stage of the disease. Aims: In some ...
Immunohistochemical evaluation of microsatellite instability in colon polyps and colorectal cancers
(Kuwait Medical Association, 2020)
Objective: Colorectal cancers (CRCs) are among the most common malignancies. In 15% of these cases, there is a defect in the DNA mismatch repair pathway, which results in microsatellite instability (MSI). Conventional ...
Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?
(Elsevier, 2021)
Background
TROP-2, a novel marker of trophoblastic cells, is being widely analyzed for its possible role in carcinogenesis and clinical behavior of various carcinomas. In this study, we aimed to evaluate the relationship ...
Immunohistochemical Expression of Cyclooxygenase-2 and Its Relationship With Prognostic Parameters in Breast Cancer
(AVES, 2021)
BACKGROUND/AIMS
Cyclooxygenase-2 (COX2) plays an important role in the development of some human cancers, especially in the development of pulmonary, colon, and breast carcinomas. Overexpression of COX2 has been involved ...